The benefit of omeprazole exposure on all-cause mortality and length of ICU/hospital stay might vary with age in critically ill pediatric patients: A cohort study-论文-万方医学网

首页> > The benefit of omeprazole exposure on all-cause mortality and length of ICU/hospital stay might vary with age in critically ill pediatric patients: A cohort study

The benefit of omeprazole exposure on all-cause mortality and length of ICU/hospital stay might vary with age in critically ill pediatric patients: A cohort study

导出原文传递

翻译打印收藏纠错

第一作者： Jiang, Fang-Fang

作者： Jiang, Fang-Fang ^[1] ; Guo, Yu ; Zhang, Zheng ; Yin, Sun-Jun ; Fan, Yu-Xin ; Huang, Yan-Hua ; Li, Ya-Jia ; Chen, Li-Rong ; Qian, Kai ; He, Gong-Hao

作者单位： EXACTCUREUniv Limoges CHU Limoges Universite de Limoges Institut National de la Sante et de la ^[1]

关键词 proton pump inhibitors Omeprazole Critically ill pediatric patients Mortality Length of stay PROTON PUMP INHIBITORS HISTAMINE H-2-RECEPTOR ANTAGONISTS FUNCTIONAL DYSPEPSIA HEART-FAILURE RISK CLOPIDOGREL RABEPRAZOLE SYMPTOMS OUTCOMES DISEASE

发布时间 2024-04-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

The benefit of omeprazole exposure on all-cause mortality and length of ICU/hospital stay might vary with age in critically ill pediatric patients: A cohort study

相似文献

同项目论文

相关期刊

检索历史 清除

The benefit of omeprazole exposure on all-cause mortality and length of ICU/hospital stay might vary with age in critically ill pediatric patients: A cohort study

相似文献

同项目论文

相关期刊

检索历史清除